Farther Finance Advisors, LLC Supernus Pharmaceuticals, Inc. Transaction History
Farther Finance Advisors, LLC
- $2.06 Trillion
- Q2 2024
A detailed history of Farther Finance Advisors, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 155 shares of SUPN stock, worth $4,960. This represents 0.0% of its overall portfolio holdings.
Number of Shares
155
Previous 94
64.89%
Holding current value
$4,960
Previous $3.15 Million
30.59%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SUPN
# of Institutions
256Shares Held
59.3MCall Options Held
47.9KPut Options Held
13.1K-
Black Rock Inc. New York, NY10.4MShares$333 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.14MShares$196 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.27MShares$169 Million1.83% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.87MShares$91.7 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.68MShares$85.8 Million0.08% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.71B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...